List of Tables
    Table 1. Global Chronic Obstructive Pulmonary Disease Therapeutics Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Chronic Obstructive Pulmonary Disease Therapeutics Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Chronic Obstructive Pulmonary Disease Therapeutics Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Chronic Obstructive Pulmonary Disease Therapeutics Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Chronic Obstructive Pulmonary Disease Therapeutics Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Chronic Obstructive Pulmonary Disease Therapeutics Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Chronic Obstructive Pulmonary Disease Therapeutics Manufacturing Sites and Area Served
    Table 11. Manufacturers Chronic Obstructive Pulmonary Disease Therapeutics Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Chronic Obstructive Pulmonary Disease Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Obstructive Pulmonary Disease Therapeutics as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Chronic Obstructive Pulmonary Disease Therapeutics Sales by Region (2017-2022) & (K Units)
    Table 16. Global Chronic Obstructive Pulmonary Disease Therapeutics Sales Market Share by Region (2017-2022)
    Table 17. Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue Market Share by Region (2017-2022)
    Table 19. North America Chronic Obstructive Pulmonary Disease Therapeutics Sales by Country (2017-2022) & (K Units)
    Table 20. North America Chronic Obstructive Pulmonary Disease Therapeutics Sales Market Share by Country (2017-2022)
    Table 21. North America Chronic Obstructive Pulmonary Disease Therapeutics Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Chronic Obstructive Pulmonary Disease Therapeutics Revenue Market Share by Country (2017-2022)
    Table 23. Europe Chronic Obstructive Pulmonary Disease Therapeutics Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Chronic Obstructive Pulmonary Disease Therapeutics Sales Market Share by Country (2017-2022)
    Table 25. Europe Chronic Obstructive Pulmonary Disease Therapeutics Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Chronic Obstructive Pulmonary Disease Therapeutics Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Chronic Obstructive Pulmonary Disease Therapeutics Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Chronic Obstructive Pulmonary Disease Therapeutics Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Chronic Obstructive Pulmonary Disease Therapeutics Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Chronic Obstructive Pulmonary Disease Therapeutics Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Chronic Obstructive Pulmonary Disease Therapeutics Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Chronic Obstructive Pulmonary Disease Therapeutics Sales Market Share by Country (2017-2022)
    Table 33. Latin America Chronic Obstructive Pulmonary Disease Therapeutics Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Chronic Obstructive Pulmonary Disease Therapeutics Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Chronic Obstructive Pulmonary Disease Therapeutics Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Chronic Obstructive Pulmonary Disease Therapeutics Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Chronic Obstructive Pulmonary Disease Therapeutics Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Chronic Obstructive Pulmonary Disease Therapeutics Revenue Market Share by Country (2017-2022)
    Table 39. Global Chronic Obstructive Pulmonary Disease Therapeutics Sales by Type (2017-2022) & (K Units)
    Table 40. Global Chronic Obstructive Pulmonary Disease Therapeutics Sales Market Share by Type (2017-2022)
    Table 41. Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue Share by Type (2017-2022)
    Table 43. Global Chronic Obstructive Pulmonary Disease Therapeutics Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units) by Application (2017-2022)
    Table 45. Global Chronic Obstructive Pulmonary Disease Therapeutics Sales Market Share by Application (2017-2022)
    Table 46. Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue Share by Application (2017-2022)
    Table 48. Global Chronic Obstructive Pulmonary Disease Therapeutics Price by Application (2017-2022) & (US$/Unit)
    Table 49. Abbott Corporation Information
    Table 50. Abbott Description and Business Overview
    Table 51. Abbott Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. Abbott Chronic Obstructive Pulmonary Disease Therapeutics Product
    Table 53. Abbott Recent Developments/Updates
    Table 54. Akorn Corporation Information
    Table 55. Akorn Description and Business Overview
    Table 56. Akorn Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. Akorn Chronic Obstructive Pulmonary Disease Therapeutics Product
    Table 58. Akorn Recent Developments/Updates
    Table 59. AbbVie Corporation Information
    Table 60. AbbVie Description and Business Overview
    Table 61. AbbVie Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. AbbVie Chronic Obstructive Pulmonary Disease Therapeutics Product
    Table 63. AbbVie Recent Developments/Updates
    Table 64. AstraZeneca Corporation Information
    Table 65. AstraZeneca Description and Business Overview
    Table 66. AstraZeneca Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. AstraZeneca Chronic Obstructive Pulmonary Disease Therapeutics Product
    Table 68. AstraZeneca Recent Developments/Updates
    Table 69. Boehringer Ingelheim Corporation Information
    Table 70. Boehringer Ingelheim Description and Business Overview
    Table 71. Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Therapeutics Product
    Table 73. Boehringer Ingelheim Recent Developments/Updates
    Table 74. Cipla Corporation Information
    Table 75. Cipla Description and Business Overview
    Table 76. Cipla Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. Cipla Chronic Obstructive Pulmonary Disease Therapeutics Product
    Table 78. Cipla Recent Developments/Updates
    Table 79. GSK Corporation Information
    Table 80. GSK Description and Business Overview
    Table 81. GSK Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. GSK Chronic Obstructive Pulmonary Disease Therapeutics Product
    Table 83. GSK Recent Developments/Updates
    Table 84. Merck Corporation Information
    Table 85. Merck Description and Business Overview
    Table 86. Merck Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 87. Merck Chronic Obstructive Pulmonary Disease Therapeutics Product
    Table 88. Merck Recent Developments/Updates
    Table 89. Mylan Corporation Information
    Table 90. Mylan Description and Business Overview
    Table 91. Mylan Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 92. Mylan Chronic Obstructive Pulmonary Disease Therapeutics Product
    Table 93. Mylan Recent Developments/Updates
    Table 94. Novartis Corporation Information
    Table 95. Novartis Description and Business Overview
    Table 96. Novartis Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 97. Novartis Chronic Obstructive Pulmonary Disease Therapeutics Product
    Table 98. Novartis Recent Developments/Updates
    Table 99. Pfizer Corporation Information
    Table 100. Pfizer Description and Business Overview
    Table 101. Pfizer Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 102. Pfizer Chronic Obstructive Pulmonary Disease Therapeutics Product
    Table 103. Pfizer Recent Developments/Updates
    Table 104. Roche Corporation Information
    Table 105. Roche Description and Business Overview
    Table 106. Roche Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 107. Roche Chronic Obstructive Pulmonary Disease Therapeutics Product
    Table 108. Roche Recent Developments/Updates
    Table 109. Teva Corporation Information
    Table 110. Teva Description and Business Overview
    Table 111. Teva Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 112. Teva Chronic Obstructive Pulmonary Disease Therapeutics Product
    Table 113. Teva Recent Developments/Updates
    Table 114. Vectura Corporation Information
    Table 115. Vectura Description and Business Overview
    Table 116. Vectura Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 117. Vectura Chronic Obstructive Pulmonary Disease Therapeutics Product
    Table 118. Vectura Recent Developments/Updates
    Table 119. Production Base and Market Concentration Rate of Raw Material
    Table 120. Key Suppliers of Raw Materials
    Table 121. Chronic Obstructive Pulmonary Disease Therapeutics Distributors List
    Table 122. Chronic Obstructive Pulmonary Disease Therapeutics Customers List
    Table 123. Chronic Obstructive Pulmonary Disease Therapeutics Market Trends
    Table 124. Chronic Obstructive Pulmonary Disease Therapeutics Market Drivers
    Table 125. Chronic Obstructive Pulmonary Disease Therapeutics Market Challenges
    Table 126. Chronic Obstructive Pulmonary Disease Therapeutics Market Restraints
    Table 127. Global Chronic Obstructive Pulmonary Disease Therapeutics Sales Forecast by Type (2023-2028) & (K Units)
    Table 128. Global Chronic Obstructive Pulmonary Disease Therapeutics Sales Market Share Forecast by Type (2023-2028)
    Table 129. Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 130. Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue Market Share Forecast by Type (2023-2028)
    Table 131. Global Chronic Obstructive Pulmonary Disease Therapeutics Sales Forecast by Application (2023-2028) & (K Units)
    Table 132. Global Chronic Obstructive Pulmonary Disease Therapeutics Sales Market Share Forecast by Application (2023-2028)
    Table 133. Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 134. Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue Market Share Forecast by Application (2023-2028)
    Table 135. Global Chronic Obstructive Pulmonary Disease Therapeutics Sales Forecast by Region (2023-2028) & (K Units)
    Table 136. Global Chronic Obstructive Pulmonary Disease Therapeutics Sales Market Share Forecast by Region (2023-2028)
    Table 137. Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 138. Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue Market Share Forecast by Region (2023-2028)
    Table 139. Research Programs/Design for This Report
    Table 140. Key Data Information from Secondary Sources
    Table 141. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Chronic Obstructive Pulmonary Disease Therapeutics
    Figure 2. Global Chronic Obstructive Pulmonary Disease Therapeutics Market Share by Type in 2021 & 2028
    Figure 3. Anti-inflammatory Drugs Product Picture
    Figure 4. Bronchodilators Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Chronic Obstructive Pulmonary Disease Therapeutics Market Share by Application in 2021 & 2028
    Figure 7. General Hospitals
    Figure 8. Specialty Clinics
    Figure 9. Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Chronic Obstructive Pulmonary Disease Therapeutics Market Size (2017-2028) & (US$ Million)
    Figure 11. Global Chronic Obstructive Pulmonary Disease Therapeutics Sales (2017-2028) & (K Units)
    Figure 12. Chronic Obstructive Pulmonary Disease Therapeutics Sales Share by Manufacturers in 2021
    Figure 13. Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue Share by Manufacturers in 2021
    Figure 14. The Global 5 and 10 Largest Chronic Obstructive Pulmonary Disease Therapeutics Players: Market Share by Revenue in 2021
    Figure 15. Chronic Obstructive Pulmonary Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 16. Global Chronic Obstructive Pulmonary Disease Therapeutics Sales Market Share by Region (2017-2022)
    Figure 17. Global Chronic Obstructive Pulmonary Disease Therapeutics Sales Market Share by Region in 2021
    Figure 18. Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue Market Share by Region (2017-2022)
    Figure 19. Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue Market Share by Region in 2021
    Figure 20. United States Chronic Obstructive Pulmonary Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Canada Chronic Obstructive Pulmonary Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Germany Chronic Obstructive Pulmonary Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. France Chronic Obstructive Pulmonary Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. U.K. Chronic Obstructive Pulmonary Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Italy Chronic Obstructive Pulmonary Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Russia Chronic Obstructive Pulmonary Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. China Chronic Obstructive Pulmonary Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Japan Chronic Obstructive Pulmonary Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. South Korea Chronic Obstructive Pulmonary Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. India Chronic Obstructive Pulmonary Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Australia Chronic Obstructive Pulmonary Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. China Taiwan Chronic Obstructive Pulmonary Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Indonesia Chronic Obstructive Pulmonary Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Thailand Chronic Obstructive Pulmonary Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Malaysia Chronic Obstructive Pulmonary Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Mexico Chronic Obstructive Pulmonary Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Brazil Chronic Obstructive Pulmonary Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Argentina Chronic Obstructive Pulmonary Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Colombia Chronic Obstructive Pulmonary Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Turkey Chronic Obstructive Pulmonary Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Saudi Arabia Chronic Obstructive Pulmonary Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. UAE Chronic Obstructive Pulmonary Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Sales Market Share of Chronic Obstructive Pulmonary Disease Therapeutics by Type (2017-2022)
    Figure 44. Manufacturing Cost Structure of Chronic Obstructive Pulmonary Disease Therapeutics
    Figure 45. Manufacturing Process Analysis of Chronic Obstructive Pulmonary Disease Therapeutics
    Figure 46. Chronic Obstructive Pulmonary Disease Therapeutics Industrial Chain Analysis
    Figure 47. Channels of Distribution
    Figure 48. Distributors Profiles
    Figure 49. Bottom-up and Top-down Approaches for This Report
    Figure 50. Data Triangulation
    Figure 51. Key Executives Interviewed